Demonstrating the Value of Interventional Radiology

 

 Permissions and Reprints

Abstract

While national healthcare expenditures per capita in the United States exceed those in all other Organisation for Economic Co-operation and Development (OECD) countries, measures of health outcomes in the United States lag behind those in peer nations. This combination of high healthcare spending and relatively poor health has led to attempts to identify high- and low-value healthcare services and to develop mechanisms to reimburse health care providers based on the value of the care delivered. This article investigates the meaning of value in healthcare and identifies specific services delivered by interventional radiologists that have accrued evidence that they meet criteria for high-value services. Recognizing the shift in reimbursement to high-value care, it is imperative that interventional radiology (IR) develop the evidence needed to articulate to all relevant stakeholders how IR contributes value to the system.

Disclosures

M.-K.F., R.C., and . A.D.T. report no financial conflicts.

Publication History

Article published online:
02 November 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

• References

• 1 U.S. Health Expenditure as GDP Share 1960-2021. Accessed July 9, 2023 at: https://www.statista.com/statistics/184968/us-health-expenditure-as-percent-of-gdp-since-1960/
  PubMed
• 2 OECD. Health Status. Accessed July 14, 2023 at: https://stats.oecd.org/Index.aspx?DataSetCode=HEALTH_STAT
  PubMed
• 3 Porter ME. What is value in health care?. N Engl J Med 2010; 363 (26) 2477-2481
  CrossrefPubMedGoogle Scholar
• 4 What Are the Components of Value-Based Care? Health Care Delivery Models | AMA Health Systems Science | AMA Ed Hub; November 14, 2019. Accessed August 25, 2023 at: edhub.ama-assn.org/health-systems-science/interactive/18028223
  PubMed
• 5 Charalel RA, McGinty G, Brant-Zawadzki M. et al. Interventional radiology delivers high-value health care and is an Imaging 3.0 vanguard. J Am Coll Radiol 2015; 12 (05) 501-506
  CrossrefPubMedGoogle Scholar
• 6 Schartz D, Young E. Medicare reimbursement trends for interventional radiology procedures: 2012 to 2020. J Vasc Interv Radiol 2021; 32 (03) 447-452
  CrossrefPubMedGoogle Scholar
• 7 Explore Measures and Activities - QPP. Accessed August 25, 2023 at: qpp.cms.gov/mips/explore-measures
  PubMed
• 8 Llovet JM, Real MI, Montaña X. et al; Barcelona Liver Cancer Group. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359 (9319): 1734-1739
  CrossrefPubMedGoogle Scholar
• 9 Gabr A, Riaz A, Johnson GE. et al. Correlation of Y90-absorbed radiation dose to pathological necrosis in hepatocellular carcinoma: confirmatory multicenter analysis in 45 explants. Eur J Nucl Med Mol Imaging 2021; 48 (02) 580-583
  CrossrefPubMedGoogle Scholar
• 10 Reig M, Forner A, Rimola J. et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. Hepatol 2022; 76: 68193
  PubMedGoogle Scholar
• 11 Liu Z, Wang Y, Yan J. et al. Uterine artery embolization versus hysterectomy in the treatment of refractory postpartum hemorrhage: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2020; 33 (04) 693-705
  CrossrefPubMedGoogle Scholar
• 12 Sapoval M, Thiounn N, Descazeaud A. et al; PARTEM Study Group. Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial. Lancet Reg Health Eur 2023; 31: 100672
  CrossrefPubMedGoogle Scholar
• 13 Knight GM, Talwar A, Salem R, Mouli S. Systematic review and meta-analysis comparing prostatic artery embolization to gold-standard transurethral resection of the prostate for benign prostatic hyperplasia. Cardiovasc Intervent Radiol 2021; 44 (02) 183-193
  CrossrefPubMedGoogle Scholar
• 14 Talenfeld AD, Gennarelli RL, Elkin EB. et al. Percutaneous ablation vs. partial and radical nephrectomy for T1a renal cancer: a population-based analysis. Ann Intern Med 2018; 169 (02) 69-77
  CrossrefPubMedGoogle Scholar
• 15 Charalel RA, Mushlin AI, Zheng X. et al. Beyond survival: complications and care delivery outcomes following early liver cancer treatment in a nationally representative cohort. J Vasc Interv Radiol 2023; S1051-0443 (23)00519-5
  PubMedGoogle Scholar
• 16 Consumer Assessment of Healthcare Providers & Systems (CAHPS). Accessed July 14, 2023 at: https://www.cms.gov/research-statistics-data-and-systems/research/cahps
  PubMed
• 17 Delgado J, Huang AJ. Improving the patient experience during musculoskeletal interventional procedures. Skeletal Radiol 2023; 52 (05) 889-895
  CrossrefPubMedGoogle Scholar
• 18 LaRoy JR, White SB, Jayakrishnan T. et al. Cost and morbidity analysis of chest port insertion: interventional radiology suite versus operating room. J Am Coll Radiol 2015; 12 (06) 563-571
  CrossrefPubMedGoogle Scholar
• 19 Trivedi PS, Jensen AM, Brown MA. et al. Cost analysis of dialysis access maintenance interventions across physician specialties in US Medicare beneficiaries. Radiology 2020; 297 (02) 474-481
  CrossrefPubMedGoogle Scholar
• 20 Pron G, Hwang M, Smith R, Cheung A, Murphy K. Cost-effectiveness studies of vertebral augmentation for osteoporotic vertebral fractures: a systematic review. Spine J 2022; 22 (08) 1356-1371
  CrossrefPubMedGoogle Scholar
• 21 SIR Data Registry. Accessed July 14, 2023 at: https://www.sirweb.org/practice-resources/quality-improvement2/data-registry/
  PubMed
• 22 HPI. Accessed July 14, 2023 at: https://www.neimanhpi.org/about/
  PubMed